Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 17552
Country/Region: Burundi
Year: 2018
Main Partner: FHI 360
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $1,500,000 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $149,672
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $144,036
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $185,723
Sexual Prevention: Other Sexual Prevention (HVOP) $849,265
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $171,304
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2019 56
GEND_GBV <10, Male, Physical and/or Emotional Violence 2019 2
GEND_GBV <10, Male, Sexual Violence (Post-Rape Care) 2019 2
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2019 41
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2019 4
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2019 91
GEND_GBV 15-19, Male, Physical and/or Emotional Violence 2019 1
GEND_GBV 15-19, Male, Sexual Violence (Post-Rape Care) 2019 3
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2019 53
GEND_GBV 20-24, Male, Physical and/or Emotional Violence 2019 1
GEND_GBV 20-24, Male, Sexual Violence (Post-Rape Care) 2019 2
GEND_GBV 25-29, Female, Sexual Violence (Post-Rape Care) 2019 3
GEND_GBV 30-34, Female, Sexual Violence (Post-Rape Care) 2019 7
GEND_GBV 35-39, Female, Sexual Violence (Post-Rape Care) 2019 1
GEND_GBV 50+, Female, Physical and/or Emotional Violence 2019 2
GEND_GBV 50+, Female, Sexual Violence (Post-Rape Care) 2019 56
GEND_GBV 50+, Male, Sexual Violence (Post-Rape Care) 2019 1
GEND_GBV By PEP service provision (related to sexual violence services provided) 2019 243
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2019 6
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2019 320
GEND_GBV Number of people receiving post-GBV care 2019 326
HTS_SELF 2019 2,876
HTS_SELF 10-14, Female, Directly-Assisted 2019 28
HTS_SELF 10-14, Female, Unassisted 2019 28
HTS_SELF 10-14, Male, Directly-Assisted 2019 28
HTS_SELF 10-14, Male, Unassisted 2019 28
HTS_SELF 15-19, Female, Directly-Assisted 2019 143
HTS_SELF 15-19, Female, Unassisted 2019 143
HTS_SELF 15-19, Male, Directly-Assisted 2019 143
HTS_SELF 15-19, Male, Unassisted 2019 143
HTS_SELF 20-24, Female, Directly-Assisted 2019 173
HTS_SELF 20-24, Female, Unassisted 2019 58
HTS_SELF 20-24, Male, Directly-Assisted 2019 173
HTS_SELF 20-24, Male, Unassisted 2019 58
HTS_SELF 25-29, Female, Directly-Assisted 2019 173
HTS_SELF 25-29, Female, Unassisted 2019 58
HTS_SELF 25-29, Male, Directly-Assisted 2019 173
HTS_SELF 25-29, Male, Unassisted 2019 58
HTS_SELF 30-34, Female, Directly-Assisted 2019 173
HTS_SELF 30-34, Female, Unassisted 2019 58
HTS_SELF 30-34, Male, Directly-Assisted 2019 173
HTS_SELF 30-34, Male, Unassisted 2019 58
HTS_SELF 35-39, Female, Directly-Assisted 2019 173
HTS_SELF 35-39, Female, Unassisted 2019 58
HTS_SELF 35-39, Male, Directly-Assisted 2019 173
HTS_SELF 35-39, Male, Unassisted 2019 58
HTS_SELF 40-49, Female, Directly-Assisted 2019 114
HTS_SELF 40-49, Female, Unassisted 2019 58
HTS_SELF 40-49, Male, Directly-Assisted 2019 114
HTS_SELF 40-49, Male, Unassisted 2019 58
HTS_SELF Directly-Assisted 2019 1,954
HTS_SELF FSW, Directly-Assisted 2019 910
HTS_SELF FSW, Unassisted 2019 444
HTS_SELF MSM, Directly-Assisted 2019 948
HTS_SELF Unassisted 2019 922
HTS_SELF Unassisted - Other 2019 182
HTS_SELF Unassisted - Self 2019 181
HTS_SELF Unassisted - Sex Partner 2019 559
HTS_TST <5, Unknown Sex, Negative 2019 27
HTS_TST 25-29, Female, Negative 2019 50
HTS_TST 25-29, Female, Negative 2019 83
HTS_TST 25-29, Female, Negative 2019 475
HTS_TST 25-29, Female, Negative 2019 15
HTS_TST 25-29, Female, Negative 2019 128
HTS_TST 25-29, Male, Negative 2019 34
HTS_TST 25-29, Male, Negative 2019 28
HTS_TST 25-29, Male, Negative 2019 533
HTS_TST 25-29, Male, Negative 2019 6
HTS_TST 25-29, Male, Negative 2019 33
HTS_TST 30-34, Female, Negative 2019 338
HTS_TST 30-34, Female, Negative 2019 76
HTS_TST 30-34, Female, Negative 2019 3,456
HTS_TST 30-34, Female, Negative 2019 98
HTS_TST 30-34, Female, Negative 2019 111
HTS_TST 30-34, Male, Negative 2019 102
HTS_TST 30-34, Male, Negative 2019 18
HTS_TST 30-34, Male, Negative 2019 1,070
HTS_TST 30-34, Male, Negative 2019 9
HTS_TST 30-34, Male, Negative 2019 15
HTS_TST 35-39, Female, Negative 2019 75
HTS_TST 35-39, Female, Negative 2019 22
HTS_TST 35-39, Female, Negative 2019 878
HTS_TST 35-39, Female, Negative 2019 30
HTS_TST 35-39, Female, Negative 2019 45
HTS_TST 35-39, Male, Negative 2019 26
HTS_TST 35-39, Male, Negative 2019 6
HTS_TST 35-39, Male, Negative 2019 480
HTS_TST 35-39, Male, Negative 2019 1
HTS_TST 35-39, Male, Negative 2019 9
HTS_TST 40-49, Female, Negative 2019 50
HTS_TST 40-49, Female, Negative 2019 2
HTS_TST 40-49, Female, Negative 2019 470
HTS_TST 40-49, Female, Negative 2019 20
HTS_TST 40-49, Female, Negative 2019 37
HTS_TST 40-49, Male, Negative 2019 16
HTS_TST 40-49, Male, Negative 2019 1
HTS_TST 40-49, Male, Negative 2019 24
HTS_TST 40-49, Male, Negative 2019 9
HTS_TST By Key Population: FSW, Negative 2019 12,866
HTS_TST By Key Population: MSM, Negative 2019 5,243
HTS_TST By Key Population: People in prisons and other enclosed settings, Negative 2019 523
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 19,878
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 1,784
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 658
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 3,803
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 1,724
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2019 109
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 1
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 84
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 35
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 33
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 161
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 78
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 357
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 144
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 34
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 52
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 33
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 84
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 34
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 3
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 4
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 8
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 2
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 6
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 55
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 10
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 111
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 29
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 11
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 92
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 75
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 26
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 138
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 35
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 22
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 8
HTS_TST_POS 25-29, Female, Positive 2019 6
HTS_TST_POS 25-29, Female, Positive 2019 91
HTS_TST_POS 25-29, Female, Positive 2019 1
HTS_TST_POS 25-29, Female, Positive 2019 1
HTS_TST_POS 25-29, Male, Positive 2019 1
HTS_TST_POS 25-29, Male, Positive 2019 43
HTS_TST_POS 30-34, Female, Positive 2019 25
HTS_TST_POS 30-34, Female, Positive 2019 192
HTS_TST_POS 30-34, Female, Positive 2019 2
HTS_TST_POS 30-34, Female, Positive 2019 3
HTS_TST_POS 30-34, Male, Positive 2019 3
HTS_TST_POS 30-34, Male, Positive 2019 11
HTS_TST_POS 35-39, Female, Positive 2019 20
HTS_TST_POS 35-39, Female, Positive 2019 124
HTS_TST_POS 35-39, Female, Positive 2019 2
HTS_TST_POS 35-39, Female, Positive 2019 1
HTS_TST_POS 35-39, Male, Positive 2019 3
HTS_TST_POS 40-49, Female, Positive 2019 6
HTS_TST_POS 40-49, Female, Positive 2019 27
HTS_TST_POS 40-49, Female, Positive 2019 1
HTS_TST_POS 40-49, Female, Positive 2019 1
HTS_TST_POS 40-49, Male, Positive 2019 1
HTS_TST_POS By Key Population: FSW, Positive 2019 982
HTS_TST_POS By Key Population: MSM, Positive 2019 119
HTS_TST_POS By Key Population: People in prisons and other enclosed settings, Positive 2019 28
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2019 47
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2019 24
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2019 412
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2019 24
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 29
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 2
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 14,412
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 788
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 1,181
KP_PREV By key population type: Transgender who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 167
KP_PREV By key population type: Transgender who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 249
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2019 16,797
TX_NEW 25-29, Female, Positive 2019 92
TX_NEW 25-29, Male, Positive 2019 33
TX_NEW 30-34, Female, Positive 2019 342
TX_NEW 30-34, Male, Positive 2019 44
TX_NEW 35-39, Female, Positive 2019 250
TX_NEW 35-39, Male, Positive 2019 28
TX_NEW 40-49, Female, Positive 2019 69
TX_NEW 40-49, Male, Positive 2019 5
TX_NEW Breastfeeding status 2019 6
TX_NEW By Age/Sex: <1 2019 3
TX_NEW By Age/Sex: 1-9 2019 3
TX_NEW By Age/Sex: 10-14 Female 2019 5
TX_NEW By Age/Sex: 10-14 Male 2019 5
TX_NEW By Age/Sex: 15-19 Female 2019 119
TX_NEW By Age/Sex: 15-19 Male 2019 1
TX_NEW By Age/Sex: 20-24 Female 2019 306
TX_NEW By Age/Sex: 20-24 Male 2019 21
TX_NEW By Age/Sex: 50+ Female 2019 44
TX_NEW FSW 2019 942
TX_NEW MSM 2019 52
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 1,370
TX_NEW Pregnancy status 2019 24
TX_NEW Sum of Age/Sex disaggregates 2019 501
Cross Cutting Budget Categories and Known Amounts Total: $1,832,781
Gender: Gender Based Violence (GBV) $16,058
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Key Populations: Sex Workers $1,089,760
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Monitoring and evaluation of SW programs
Key Populations: MSM and TG $398,792
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Monitoring and evaluation of MSM/TG programs
Condoms: Commodities $5,316
Human Resources for Health $322,855